Oxurion Announces Extraordinary General Shareholders' Meeting
Leuven, BELGIUM - June 4, 2024 - 07:00 PM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces an extraordinary general shareholders' meeting to be held on Thursday July 4, 2024 at 11:00 AM (CET).
This extraordinary general shareholders' meeting regards the proposal of share consolidation in respect of all outstanding shares of the Company by means of a 1-for-10,000 share consolidation.
The convening notice and other documents pertaining to the shareholders' meeting, can be consulted on Oxurion's website Oxurion/shareholders.
About Oxurion
Oxurion.
Please contact for additional information:
| Oxurion NV Pascal Ghoson Chief Executive Officer pascal.ghoson@oxurion.com (mailto:pascal.ghoson@oxurion.com) | Backstage Communication Jurgen Vluijmans Partner jurgen@backstagecom.be (mailto:jurgen@backstagecom.be) |
Attachment
- NL (https://ml-eu.globenewswire.com/Resource/Download/45d6a401-b79e-4cd2-9edc-0613d57935d2)
© 2024 GlobeNewswire (Europe)
